Universitätsspital Zürich
Zurich, Switzerland
15 recruiting
Showing 1–15 of 15 trials
Recruiting
Phase 3
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Breast Cancer
Stemline Therapeutics, Inc.4,220 enrolled524 locationsNCT06492616
Recruiting
Phase 3
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Uveal Melanoma
IDEAYA Biosciences520 enrolled87 locationsNCT07015190
Recruiting
European Real-World Registry for Use of the Ion Endoluminal System
Lung CancerPulmonary Nodule
Intuitive Surgical1,200 enrolled5 locationsNCT06923774
Recruiting
Phase 2
Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial
GlioblastomaRecurrence Tumor
Centre Hospitalier Universitaire Vaudois59 enrolled7 locationsNCT07263438
Recruiting
DESTINY Breast Respond HER2-low Europe
Metastatic Breast CancerUnresectable Breast CancerHER2-low Expressing Breast Cancer
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1,155 enrolled211 locationsNCT05945732
Recruiting
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Prostate Cancer
Prostate Cancer Clinical Trials Consortium5,000 enrolled121 locationsNCT03151629
Recruiting
Phase 2
Feasibility of Total Neoadjuvant Treatment With HYPErthermia in Patients With High-risk Extremity and Trunk Soft Tissue Sarcoma (TNT-HYPE)
Sarcoma,Soft Tissue
Swiss Cancer Institute24 enrolled8 locationsNCT06835049
Recruiting
Pragmatic Geriatric Assessment Before CAR-T or Bispecific Antibody Therapy to Predict Side Effects and Outcomes in Older Patients (GA-ACT Trial)
Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), LymphomaCART TherapyBispecific Antibody+1 more
University of Zurich208 enrolled2 locationsNCT07309497
Recruiting
Phase 2
PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC
Locally AdvancedStage III Non-small Cell Lung CancerUnresectable
TheraOp110 enrolled11 locationsNCT06102057
Recruiting
Phase 3
Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer
MelanomaNon-small Cell Lung Cancer
ETOP IBCSG Partners Foundation180 enrolled15 locationsNCT05522660
Recruiting
Phase 2Phase 3
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Advanced Melanoma
Eikon Therapeutics740 enrolled77 locationsNCT06697301
Recruiting
Not Applicable
Restrictive Use of Dexamethasone in Glioblastoma
GlioblastomaDexamethasoneSteroids
Insel Gruppe AG, University Hospital Bern50 enrolled4 locationsNCT04266977
Recruiting
Not Applicable
Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV NSCL Cancer Patients
Non-small Cell Lung Cancer (NSCLC)Stage IV
Swiss Cancer Institute128 enrolled7 locationsNCT06114108
Recruiting
Therapy-Associated Saliva and Taste Change Evaluation (TASTE) in Head & Neck Cancer Patients Undergoing Radiotherapy
Head and Neck Cancer
Sonja Stieb, MD150 enrolled3 locationsNCT06444776
Recruiting
Not Applicable
AMEND-CRT: Mechanical Dyssynchrony as Selection Criterion for CRT
Heart FailureCardiac Remodeling, VentricularCardiomyopathy, Dilated+1 more
Universitaire Ziekenhuizen KU Leuven700 enrolled24 locationsNCT04225520